Fig. 4: Forest plots of patient outcomes from sensitivity analysis that included only data from RCTs or RCT treatment arms in which doses of surfactant were given according to the US product label. | Journal of Perinatology

Fig. 4: Forest plots of patient outcomes from sensitivity analysis that included only data from RCTs or RCT treatment arms in which doses of surfactant were given according to the US product label.

From: Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials

Fig. 4: Forest plots of patient outcomes from sensitivity analysis that included only data from RCTs or RCT treatment arms in which doses of surfactant were given according to the US product label.The alternative text for this image may have been generated using AI.

ALS air leak syndrome, BPD bronchopulmonary dysplasia, CI confidence interval, OR odds ratio, RCT randomized controlled trial.

Back to article page